000590 Tus-Pharmaceutical Group
- 4.99
- -0.01-0.20%
Tus-Pharmaceutical Group News
Tus-Pharmaceutical Group: Announcement regarding the pledge of a portion of the equity of one of the controlling shareholders by the concerted action person.
Tus-Pharmaceutical Group: Announcement on the Release of Certain Pledged Equity by One of the Company's Controlling Shareholders Jointly Acting Persons in 2024-032.
Tus-Pharmaceutical Group: 2024 Interim Performance Forecast
Tus-Pharmaceutical Group: Announcement of the resolution of the Tenth Board of Directors' temporary meeting.
Tus-Pharmaceutical Group: Announcement Regarding Appointment of Secretary of the Board of Directors
Tus-Pharmaceutical Group: Announcement regarding the resignation of the company's vice president and board of directors secretary.
Tus-Pharmaceutical Group: Legal opinion on the 2023 shareholder meeting of Tus-Pharmaceutical Group Co., Ltd.
Tus-Pharmaceutical Group: Announcement of resolutions of the 2023 Shareholders' Meeting (2024-027)
Tus-Pharmaceutical Group: Announcement Regarding the Intention to Reappoint the Accounting Firm.
Tus-Pharmaceutical Group: Announcement on amending the Company's Articles of Association.
Tus-Pharmaceutical Group: Group funds management system.
Tus-Pharmaceutical Group: Investment management system
Tus-Pharmaceutical Group: Announcement of the resolution of the Tenth Board of Directors' temporary meeting.
Tus-Pharmaceutical Group: Fundraising Management Measures
Tus-Pharmaceutical Group: Anti-fraud system
Tus-Pharmaceutical Group: Notice on holding the shareholder meeting for the year 2023.
Tus-Pharmaceutical Group: Internal Audit Management Standards
Tus-Pharmaceutical Group: Materials for the 2023 Shareholders' Meeting.
Tus-Pharmaceutical Group: An indicative announcement on the free transfer of the company's shareholders' state-owned shares and changes in shareholders' rights
Tus-Pharmaceutical Group: 2024 First Quarter Report
Analysis
Price Target
No Data
